Healthcare Costs of Pediatric Acne in the Medicaid Population: A Retrospective Analysis
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 16, Issue 3
Abstract
Despite the substantial economic burden of acne, little is known about healthcare costs in Medicaid-enrolled pediatric patients with acne. The objective of this study is to examine factors associated with healthcare costs in Medicaid-enrolled pediatric patients with acne. As a retrospective analysis, patients were included if they: (1) had at least one medical claim containing a code for a diagnosis of acne; (2) had at least one acne-related medication claim; and (3) were aged 17 years and younger. The Marketscan Medicaid Database was used. The dependent variables were prescription costs, outpatient visit costs, and total healthcare costs. The independent variables were age, gender, race/ethnicity, the Charlson Comorbidity Index (CCI), medication type, medication refills, and medication adherence. Generalized linear models with a gamma distribution, a log-link function, and two-part model were conducted. Among 21,846 patients included, the mean total healthcare costs were $109 (SD=134) during the 90-day post index periods. The predictive mean acne-related total healthcare costs in patients aged 12 to 17 years ($117) and blacks ($115) was higher than those aged less than 5 years ($90), 6 to 11 years ($81), and whites ($109). Gender and CCI were not associated with changed total healthcare costs. Oral antibiotics and oral contraceptive use was associated with decreased costs, while use of topical antibiotics, retinoids, and glucocorticoids was associated with increased costs. Age group, race/ethnicity, acne-related medication type, acne-related medication refills, and acne-related medication adherence were associated with acne-related total healthcare costs.
Authors and Affiliations
Chanhyun Park, Minyoung Sung, Sean Hyungwoo Kim, Denise Pinal, Rajesh Balkrishnan, Jongwha Chang
Keywords
Related Articles
- EP ID EP312911
- DOI 10.9734/BJPR/2017/33274
- Views 112
- Downloads 0
Antioxidant and Cytotoxic Activities of Gmelina arborea ROXB. Leaves
Aims: The leaves of Gmelina arborea (ROXB.) (Family Verbenaceae) are widely used in the folklore to treat various types of diseases. In this study, the antioxidant and cytotoxic activities of different methanolic extract...
Free Radical Scavenging Activity and Protein Concentration and Profile of the Blowfly Maggot (Lucilia robineau) Excretion/Saliva Extract
Aim: The aim of this study was to determine the free radical scavenging activity, Protein concentration and profile of Blowfly maggot (Lucilia robineau) excretion/secretion (ES). Place and Duration of Study: Maggot sampl...
Prophylactic Effect of Clofibrate on Hyperbilirubinemia in Very Low Birth Weight Twins
Aims: To determine the prophylactic effects of clofibrate on hyperbilirubinemia in very low birth weight twins. Study Design: A randomized double blind clinical trial Place and Duration of Study: Department of Neonatal...
Phenolic Contents and In vitro Pharmacological Activities of Methanolic Extract of Pterocarpus erinaceus Poir. Stem Bark (Fabaceae)
Aim: To investigate the cytotoxic effect of methanol extract of Ptreocarpus erinaceus stem barks against cancer lines (Leukemia cell K562 and lung small cells A549) and its inhibition effects against NF-кB activation and...
Thaumatococcus daniellii Extract Modulates Glibenclamide Activity and Ameliorates Heamatological Disorders, Oxidative Stress and Dyslipidemia Associated with Diabetes Mellitus in Rats
Aims: Native practices in poor regions of Africa takes local herbs with orthodox medicine for treatment of diabetes. This study investigates the roles of Thaumatococcus daniellii methanol leaves extract in combination wi...